Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 134

1.

A Mendelian randomization study of IL6 signaling in cardiovascular diseases, immune-related disorders and longevity.

Rosa M, Chignon A, Li Z, Boulanger MC, Arsenault BJ, Bossé Y, Thériault S, Mathieu P.

NPJ Genom Med. 2019 Sep 20;4:23. doi: 10.1038/s41525-019-0097-4. eCollection 2019.

2.

apoB/apoA-I Ratio and Lp(a) Associations With Aortic Valve Stenosis Incidence: Insights From the EPIC-Norfolk Prospective Population Study.

Zheng KH, Arsenault BJ, Kaiser Y, Khaw KT, Wareham NJ, Stroes ESG, Boekholdt SM.

J Am Heart Assoc. 2019 Aug 20;8(16):e013020. doi: 10.1161/JAHA.119.013020. Epub 2019 Aug 13.

3.

Visceral and ectopic fat, atherosclerosis, and cardiometabolic disease: a position statement.

Neeland IJ, Ross R, Després JP, Matsuzawa Y, Yamashita S, Shai I, Seidell J, Magni P, Santos RD, Arsenault B, Cuevas A, Hu FB, Griffin B, Zambon A, Barter P, Fruchart JC, Eckel RH; International Atherosclerosis Society; International Chair on Cardiometabolic Risk Working Group on Visceral Obesity.

Lancet Diabetes Endocrinol. 2019 Sep;7(9):715-725. doi: 10.1016/S2213-8587(19)30084-1. Epub 2019 Jul 10. Review.

4.

Human high-density lipoprotein microtranscriptome is unique and suggests an extended role in lipid metabolism.

Desgagné V, Guérin R, Guay SP, Boyer M, Hutchins E, Picard S, Maréchal A, Corbin F, Keuren-Jensen KV, Arsenault BJ, Bouchard L.

Epigenomics. 2019 Jun;11(8):917-934. doi: 10.2217/epi-2018-0161. Epub 2019 May 30.

PMID:
31144512
5.

Genetic Variation in LPA, Calcific Aortic Valve Stenosis in Patients Undergoing Cardiac Surgery, and Familial Risk of Aortic Valve Microcalcification.

Perrot N, Thériault S, Dina C, Chen HY, Boekholdt SM, Rigade S, Després AA, Poulin A, Capoulade R, Le Tourneau T, Messika-Zeitoun D, Trottier M, Tessier M, Guimond J, Nadeau M, Engert JC, Khaw KT, Wareham NJ, Dweck MR, Mathieu P, Pibarot P, Schott JJ, Thanassoulis G, Clavel MA, Bossé Y, Arsenault BJ.

JAMA Cardiol. 2019 Jul 1;4(7):620-627. doi: 10.1001/jamacardio.2019.1581. Erratum in: JAMA Cardiol. 2019 Jul 1;4(7):714.

PMID:
31141105
6.

Lipoprotein(a) and Oxidized Phospholipids Promote Valve Calcification in Patients With Aortic Stenosis.

Zheng KH, Tsimikas S, Pawade T, Kroon J, Jenkins WSA, Doris MK, White AC, Timmers NKLM, Hjortnaes J, Rogers MA, Aikawa E, Arsenault BJ, Witztum JL, Newby DE, Koschinsky ML, Fayad ZA, Stroes ESG, Boekholdt SM, Dweck MR.

J Am Coll Cardiol. 2019 May 7;73(17):2150-2162. doi: 10.1016/j.jacc.2019.01.070.

7.

Effect of PPARγ agonist on aerobic exercise capacity in relation to body fat distribution in men with type 2 diabetes mellitus and coronary artery disease: a 1-yr randomized study.

Bastien M, Poirier P, Brassard P, Arsenault BJ, Bertrand OF, Després JP, Costerousse O, Piché ME.

Am J Physiol Endocrinol Metab. 2019 Jul 1;317(1):E65-E73. doi: 10.1152/ajpendo.00505.2018. Epub 2019 Apr 9.

PMID:
30964707
8.

Association of Chromosome 9p21 With Subsequent Coronary Heart Disease Events.

Patel RS, Schmidt AF, Tragante V, McCubrey RO, Holmes MV, Howe LJ, Direk K, Åkerblom A, Leander K, Virani SS, Kaminski KA, Muehlschlegel JD, Dubé MP, Allayee H, Almgren P, Alver M, Baranova EV, Behlouli H, Boeckx B, Braund PS, Breitling LP, Delgado G, Duarte NE, Dufresne L, Eriksson N, Foco L, Gijsberts CM, Gong Y, Hartiala J, Heydarpour M, Hubacek JA, Kleber M, Kofink D, Kuukasjärvi P, Lee VV, Leiherer A, Lenzini PA, Levin D, Lyytikäinen LP, Martinelli N, Mons U, Nelson CP, Nikus K, Pilbrow AP, Ploski R, Sun YV, Tanck MWT, Tang WHW, Trompet S, van der Laan SW, van Setten J, Vilmundarson RO, Viviani Anselmi C, Vlachopoulou E, Boerwinkle E, Briguori C, Carlquist JF, Carruthers KF, Casu G, Deanfield J, Deloukas P, Dudbridge F, Fitzpatrick N, Gigante B, James S, Lokki ML, Lotufo PA, Marziliano N, Mordi IR, Muhlestein JB, Newton Cheh C, Pitha J, Saely CH, Samman-Tahhan A, Sandesara PB, Teren A, Timmis A, Van de Werf F, Wauters E, Wilde AAM, Ford I, Stott DJ, Algra A, Andreassi MG, Ardissino D, Arsenault BJ, Ballantyne CM, Bergmeijer TO, Bezzina CR, Body SC, Bogaty P, de Borst GJ, Brenner H, Burkhardt R, Carpeggiani C, Condorelli G, Cooper-DeHoff RM, Cresci S, de Faire U, Doughty RN, Drexel H, Engert JC, Fox KAA, Girelli D, Hagström E, Hazen SL, Held C, Hemingway H, Hoefer IE, Hovingh GK, Johnson JA, de Jong PA, Jukema JW, Kaczor MP, Kähönen M, Kettner J, Kiliszek M, Klungel OH, Lagerqvist B, Lambrechts D, Laurikka JO, Lehtimäki T, Lindholm D, Mahmoodi BK, Maitland-van der Zee AH, McPherson R, Melander O, Metspalu A, Pepinski W, Olivieri O, Opolski G, Palmer CN, Pasterkamp G, Pepine CJ, Pereira AC, Pilote L, Quyyumi AA, Richards AM, Sanak M, Scholz M, Siegbahn A, Sinisalo J, Smith JG, Spertus JA, Stewart AFR, Szczeklik W, Szpakowicz A, Ten Berg JM, Thanassoulis G, Thiery J, van der Graaf Y, Visseren FLJ, Waltenberger J; CARDIoGRAMPlusC4D Consortium, Van der Harst P, Tardif JC, Sattar N, Lang CC, Pare G, Brophy JM, Anderson JL, März W, Wallentin L, Cameron VA, Horne BD, Samani NJ, Hingorani AD, Asselbergs FW.

Circ Genom Precis Med. 2019 Apr;12(4):e002471. doi: 10.1161/CIRCGEN.119.002471. Epub 2019 Mar 21.

PMID:
30897348
9.

Subsequent Event Risk in Individuals With Established Coronary Heart Disease.

Patel RS, Tragante V, Schmidt AF, McCubrey RO, Holmes MV, Howe LJ, Direk K, Åkerblom A, Leander K, Virani SS, Kaminski KA, Muehlschlegel JD, Allayee H, Almgren P, Alver M, Baranova EV, Behloui H, Boeckx B, Braund PS, Breitling LP, Delgado G, Duarte NE, Dubé MP, Dufresne L, Eriksson N, Foco L, Scholz M, Gijsberts CM, Glinge C, Gong Y, Hartiala J, Heydarpour M, Hubacek JA, Kleber M, Kofink D, Kotti S, Kuukasjärvi P, Lee VV, Leiherer A, Lenzini PA, Levin D, Lyytikäinen LP, Martinelli N, Mons U, Nelson CP, Nikus K, Pilbrow AP, Ploski R, Sun YV, Tanck MWT, Tang WHW, Trompet S, van der Laan SW, Van Setten J, Vilmundarson RO, Viviani Anselmi C, Vlachopoulou E, Al Ali L, Boerwinkle E, Briguori C, Carlquist JF, Carruthers KF, Casu G, Deanfield J, Deloukas P, Dudbridge F, Engstrøm T, Fitzpatrick N, Fox K, Gigante B, James S, Lokki ML, Lotufo PA, Marziliano N, Mordi IR, Muhlestein JB, Newton-Cheh C, Pitha J, Saely CH, Samman-Tahhan A, Sandesara PB, Teren A, Timmis A, Van de Werf F, Wauters E, Wilde AAM, Ford I, Stott DJ, Algra A, Andreassi MG, Ardissino D, Arsenault BJ, Ballantyne CM, Bergmeijer TO, Bezzina CR, Body SC, Boersma EH, Bogaty P, Bots ML, Brenner H, Brugts JJ, Burkhardt R, Carpeggiani C, Condorelli G, Cooper-DeHoff RM, Cresci S, Danchin N, de Faire U, Doughty RN, Drexel H, Engert JC, Fox KAA, Girelli D, Grobbee DE, Hagström E, Hazen SL, Held C, Hemingway H, Hoefer IE, Hovingh GK, Jabbari R, Johnson JA, Jukema JW, Kaczor MP, Kähönen M, Kettner J, Kiliszek M, Klungel OH, Lagerqvist B, Lambrechts D, Laurikka JO, Lehtimäki T, Lindholm D, Mahmoodi BK, Maitland-van der Zee AH, McPherson R, Melander O, Metspalu A, Niemcunowicz-Janica A, Olivieri O, Opolski G, Palmer CN, Pasterkamp G, Pepine CJ, Pereira AC, Pilote L, Quyyumi AA, Richards AM, Sanak M, Siegbahn A, Simon T, Sinisalo J, Smith JG, Spertus JA, Stender S, Stewart AFR, Szczeklik W, Szpakowicz A, Tardif JC, Ten Berg JM, Tfelt-Hansen J, Thanassoulis G, Thiery J, Torp-Pedersen C, van der Graaf Y, Visseren FLJ, Waltenberger J, Weeke PE, Van der Harst P, Lang CC, Sattar N, Cameron VA, Anderson JL, Brophy JM, Pare G, Horne BD, März W, Wallentin L, Samani NJ, Hingorani AD, Asselbergs FW.

Circ Genom Precis Med. 2019 Apr;12(4):e002470. doi: 10.1161/CIRCGEN.119.002470. Epub 2019 Mar 21.

PMID:
30896328
10.

Acute and chronic effect of bariatric surgery on circulating autotaxin levels.

Bourgeois R, Piché ME, Auclair A, Grenier-Larouche T, Mitchell PL, Poirier P, Biertho L, Marceau S, Hould FS, Biron S, Lebel S, Lescelleur O, Julien F, Martin J, Tchernof A, Mathieu P, Carpentier AC, Arsenault BJ.

Physiol Rep. 2019 Mar;7(5):e14004. doi: 10.14814/phy2.14004.

11.

PCSK9 Involvement in Aortic Valve Calcification.

Poggio P, Songia P, Cavallotti L, Barbieri SS, Zanotti I, Arsenault BJ, Valerio V, Ferri N, Capoulade R, Camera M.

J Am Coll Cardiol. 2018 Dec 18;72(24):3225-3227. doi: 10.1016/j.jacc.2018.09.063. No abstract available.

PMID:
30545459
12.

Multimarker Approach to Identify Patients With Higher Mortality and Rehospitalization Rate After Surgical Aortic Valve Replacement for Aortic Stenosis.

Lindman BR, Clavel MA, Abu-Alhayja'a R, Côté N, Dagenais F, Novak E, Voisine P, Poulin A, Arsenault BJ, Desmeules P, Dahou A, Taster L, Aldahoun K, Bossé Y, Mathieu P, Pibarot P.

JACC Cardiovasc Interv. 2018 Nov 12;11(21):2172-2181. doi: 10.1016/j.jcin.2018.07.039.

PMID:
30409274
13.

Activated platelets promote an osteogenic programme and the progression of calcific aortic valve stenosis.

Bouchareb R, Boulanger MC, Tastet L, Mkannez G, Nsaibia MJ, Hadji F, Dahou A, Messadeq Y, Arsenault BJ, Pibarot P, Bossé Y, Marette A, Mathieu P.

Eur Heart J. 2019 May 1;40(17):1362-1373. doi: 10.1093/eurheartj/ehy696.

PMID:
30395215
14.

Life's simple 7 and calcific aortic valve stenosis incidence in apparently healthy men and women.

Perrot N, Boekholdt SM, Mathieu P, Wareham NJ, Khaw KT, Arsenault BJ.

Int J Cardiol. 2018 Oct 15;269:226-228. doi: 10.1016/j.ijcard.2018.07.107. Epub 2018 Jul 24.

15.

Hemodynamic Deterioration of Surgically Implanted Bioprosthetic Aortic Valves.

Salaun E, Mahjoub H, Dahou A, Mathieu P, Larose É, Després JP, Rodés-Cabau J, Arsenault BJ, Puri R, Clavel MA, Pibarot P.

J Am Coll Cardiol. 2018 Jul 17;72(3):241-251. doi: 10.1016/j.jacc.2018.04.064. Epub 2018 Jul 9.

16.

Soluble CD14 is associated with the structural failure of bioprostheses.

Nsaibia MJ, Boulanger MC, Bouchareb R, Mkannez G, Dahou A, Salaun E, Bossé Y, Clavel MA, Arsenault BJ, Pibarot P, Mathieu P.

Clin Chim Acta. 2018 Oct;485:173-177. doi: 10.1016/j.cca.2018.06.045. Epub 2018 Jun 30.

PMID:
29966619
17.

Impact of a one-year lifestyle modification program on cholesterol efflux capacities in men with abdominal obesity and dyslipidemia.

Boyer M, Mitchell PL, Poirier P, Alméras N, Tremblay A, Bergeron J, Després JP, Arsenault BJ.

Am J Physiol Endocrinol Metab. 2018 Oct 1;315(4):E460-E468. doi: 10.1152/ajpendo.00127.2018. Epub 2018 Jun 5.

18.

Longitudinal Changes in Cholesterol Efflux Capacities in Patients With Coronary Artery Disease Undergoing Lifestyle Modification Therapy.

Boyer M, Lévesque V, Poirier P, Marette A, Mitchell PL, Mora S, Mathieu P, Després JP, Larose É, Arsenault BJ.

J Am Heart Assoc. 2018 Jun 1;7(11). pii: e008681. doi: 10.1161/JAHA.118.008681.

19.

Therapeutic Agents Targeting Cardiometabolic Risk for Preventing and Treating Atherosclerotic Cardiovascular Diseases.

Arsenault BJ, Perrot N, Puri R.

Clin Pharmacol Ther. 2018 Aug;104(2):257-268. doi: 10.1002/cpt.1110. Epub 2018 Jun 19. Review.

PMID:
29737015
20.

Saturated Fats from Butter but Not from Cheese Increase HDL-Mediated Cholesterol Efflux Capacity from J774 Macrophages in Men and Women with Abdominal Obesity.

Brassard D, Arsenault BJ, Boyer M, Bernic D, Tessier-Grenier M, Talbot D, Tremblay A, Levy E, Asztalos B, Jones PJH, Couture P, Lamarche B.

J Nutr. 2018 Apr 1;148(4):573-580. doi: 10.1093/jn/nxy014.

PMID:
29659963
21.

Rosiglitazone lowers resting and blood pressure response to exercise in men with type 2 diabetes: A 1-year randomized study.

Piché ME, Laberge AS, Brassard P, Arsenault BJ, Bertrand OF, Després JP, Costerousse O, Poirier P.

Diabetes Obes Metab. 2018 Jul;20(7):1740-1750. doi: 10.1111/dom.13293. Epub 2018 Apr 19.

PMID:
29573098
22.

ApoB/ApoA-I Ratio is Associated With Faster Hemodynamic Progression of Aortic Stenosis: Results From the PROGRESSA (Metabolic Determinants of the Progression of Aortic Stenosis) Study.

Tastet L, Capoulade R, Shen M, Clavel MA, Côté N, Mathieu P, Arsenault M, Bédard É, Tremblay A, Samson M, Bossé Y, Dumesnil JG, Arsenault BJ, Beaudoin J, Bernier M, Després JP, Pibarot P.

J Am Heart Assoc. 2018 Feb 10;7(4). pii: e007980. doi: 10.1161/JAHA.117.007980.

23.

Gene expression analysis in asthma using a targeted multiplex array.

Pascoe CD, Obeidat M, Arsenault BA, Nie Y, Warner S, Stefanowicz D, Wadsworth SJ, Hirota JA, Jasemine Yang S, Dorscheid DR, Carlsten C, Hackett TL, Seow CY, Paré PD.

BMC Pulm Med. 2017 Dec 11;17(1):189. doi: 10.1186/s12890-017-0545-9.

24.

Effect of atorvastatin, cholesterol ester transfer protein inhibition, and diabetes mellitus on circulating proprotein subtilisin kexin type 9 and lipoprotein(a) levels in patients at high cardiovascular risk.

Arsenault BJ, Petrides F, Tabet F, Bao W, Hovingh GK, Boekholdt SM, Ramin-Mangata S, Meilhac O, DeMicco D, Rye KA, Waters DD, Kastelein JJP, Barter P, Lambert G.

J Clin Lipidol. 2018 Jan - Feb;12(1):130-136. doi: 10.1016/j.jacl.2017.10.001. Epub 2017 Oct 12.

25.

Do Oxidized Lipoproteins Cause Atherosclerotic Cardiovascular Diseases?

Arsenault BJ, Bourgeois R, Mathieu P.

Can J Cardiol. 2017 Dec;33(12):1513-1516. doi: 10.1016/j.cjca.2017.09.016. Epub 2017 Oct 6. No abstract available.

PMID:
29100654
26.

Acute and Chronic Impact of Bariatric Surgery on Plasma LDL Cholesterol and PCSK9 Levels in Patients With Severe Obesity.

Boyer M, Piché ME, Auclair A, Grenier-Larouche T, Biertho L, Marceau S, Hould FS, Biron S, Lebel S, Lescelleur O, Julien F, Martin J, Tchernof A, Carpentier AC, Poirier P, Arsenault BJ.

J Clin Endocrinol Metab. 2017 Nov 1;102(11):4023-4030. doi: 10.1210/jc.2017-00699.

PMID:
28938493
27.

Interplay between cigarette smoking and pulmonary reverse lipid transport.

Jubinville É, Talbot M, Bérubé JC, Hamel-Auger M, Maranda-Robitaille M, Beaulieu MJ, Aubin S, Paré MÈ, Kallend DG, Arsenault B, Bossé Y, Morissette MC.

Eur Respir J. 2017 Sep 9;50(3). pii: 1700681. doi: 10.1183/13993003.00681-2017. Print 2017 Sep.

28.

Precision Nutrition: A Review of Personalized Nutritional Approaches for the Prevention and Management of Metabolic Syndrome.

de Toro-Martín J, Arsenault BJ, Després JP, Vohl MC.

Nutrients. 2017 Aug 22;9(8). pii: E913. doi: 10.3390/nu9080913. Review.

29.

Coronary Artery Disease Affects Symptomatology of Aortic Valve Stenosis.

Boekholdt SM, Arsenault BJ, Mathieu P.

J Am Coll Cardiol. 2017 Aug 22;70(8):1103-1104. doi: 10.1016/j.jacc.2017.04.072. No abstract available.

30.

Pathobiology of Lp(a) in calcific aortic valve disease.

Mathieu P, Arsenault BJ, Boulanger MC, Bossé Y, Koschinsky ML.

Expert Rev Cardiovasc Ther. 2017 Oct;15(10):797-807. doi: 10.1080/14779072.2017.1367286. Epub 2017 Aug 24. Review.

PMID:
28816078
31.

Lipoprotein(a) and coronary atheroma progression rates during long-term high-intensity statin therapy: Insights from SATURN.

Puri R, Ballantyne CM, Hoogeveen RC, Shao M, Barter P, Libby P, Chapman MJ, Erbel R, Arsenault BJ, Raichlen JS, Nissen SE, Nicholls SJ.

Atherosclerosis. 2017 Aug;263:137-144. doi: 10.1016/j.atherosclerosis.2017.06.026. Epub 2017 Jun 15.

PMID:
28641153
32.

Targeting Overconsumption of Sugar-Sweetened Beverages vs. Overall Poor Diet Quality for Cardiometabolic Diseases Risk Prevention: Place Your Bets!

Arsenault BJ, Lamarche B, Després JP.

Nutrients. 2017 Jun 13;9(6). pii: E600. doi: 10.3390/nu9060600. Review.

33.

OxLDL-derived lysophosphatidic acid promotes the progression of aortic valve stenosis through a LPAR1-RhoA-NF-κB pathway.

Nsaibia MJ, Boulanger MC, Bouchareb R, Mkannez G, Le Quang K, Hadji F, Argaud D, Dahou A, Bossé Y, Koschinsky ML, Pibarot P, Arsenault BJ, Marette A, Mathieu P.

Cardiovasc Res. 2017 Sep 1;113(11):1351-1363. doi: 10.1093/cvr/cvx089.

34.

CAVD: civilization aortic valve disease.

Mathieu P, Arsenault BJ.

Eur Heart J. 2017 Jul 21;38(28):2198-2200. doi: 10.1093/eurheartj/ehx219. No abstract available.

35.

Mortality in the Familial Atherosclerosis Treatment Study-Observational Study.

Poirier P, Marette A, Després JP, Larose É, Arsenault BJ.

J Clin Lipidol. 2017 Jan - Feb;11(1):309-310. doi: 10.1016/j.jacl.2017.01.008. Epub 2017 Jan 23. No abstract available.

PMID:
28391906
36.

Autoantibodies and immune complexes to oxidation-specific epitopes and progression of aortic stenosis: Results from the ASTRONOMER trial.

Capoulade R, Chan KL, Mathieu P, Bossé Y, Dumesnil JG, Tam JW, Teo KK, Yang X, Witztum JL, Arsenault BJ, Després JP, Pibarot P, Tsimikas S.

Atherosclerosis. 2017 May;260:1-7. doi: 10.1016/j.atherosclerosis.2017.03.013. Epub 2017 Mar 9.

PMID:
28319871
37.

Cardiovascular disease prevention: lifestyle attenuation of genetic risk.

Arsenault BJ, Després JP.

Nat Rev Cardiol. 2017 Apr;14(4):187-188. doi: 10.1038/nrcardio.2017.20. Epub 2017 Feb 16. No abstract available.

PMID:
28202900
38.

Benoit Arsenault on lifestyle, lipids and social media.

Arsenault B.

Future Sci OA. 2015 Nov 1;1(3):FSO10. doi: 10.4155/fso.15.8. eCollection 2015 Nov.

39.

Does lifestyle contribute to disease severity in patients with inherited lipid disorders?

Arsenault BJ, Perrot N, Couture P.

Curr Opin Lipidol. 2017 Apr;28(2):177-185. doi: 10.1097/MOL.0000000000000387. Review.

PMID:
28030378
40.

Ideal cardiovascular health influences cardiovascular disease risk associated with high lipoprotein(a) levels and genotype: The EPIC-Norfolk prospective population study.

Perrot N, Verbeek R, Sandhu M, Boekholdt SM, Hovingh GK, Wareham NJ, Khaw KT, Arsenault BJ.

Atherosclerosis. 2017 Jan;256:47-52. doi: 10.1016/j.atherosclerosis.2016.11.010. Epub 2016 Nov 11.

41.

Impact of a 1-year lifestyle modification program on plasma lipoprotein and PCSK9 concentrations in patients with coronary artery disease.

Boyer M, Lévesque V, Poirier P, Marette A, Mathieu P, Després JP, Larose É, Arsenault BJ.

J Clin Lipidol. 2016 Nov - Dec;10(6):1353-1361. doi: 10.1016/j.jacl.2016.08.014. Epub 2016 Sep 2.

PMID:
27919352
42.

Carriers of the PCSK9 R46L Variant Are Characterized by an Antiatherogenic Lipoprotein Profile Assessed by Nuclear Magnetic Resonance Spectroscopy-Brief Report.

Verbeek R, Boyer M, Boekholdt SM, Hovingh GK, Kastelein JJ, Wareham N, Khaw KT, Arsenault BJ.

Arterioscler Thromb Vasc Biol. 2017 Jan;37(1):43-48. doi: 10.1161/ATVBAHA.116.307995. Epub 2016 Nov 17.

43.

Predicting Prognosis in Acute Coronary Syndromes: Makeover Time for TIMI and GRACE?

Waters DD, Arsenault BJ.

Can J Cardiol. 2016 Nov;32(11):1290-1293. doi: 10.1016/j.cjca.2016.02.053. Epub 2016 Feb 21. No abstract available.

PMID:
27062237
44.

Autotaxin interacts with lipoprotein(a) and oxidized phospholipids in predicting the risk of calcific aortic valve stenosis in patients with coronary artery disease.

Nsaibia MJ, Mahmut A, Boulanger MC, Arsenault BJ, Bouchareb R, Simard S, Witztum JL, Clavel MA, Pibarot P, Bossé Y, Tsimikas S, Mathieu P.

J Intern Med. 2016 Nov;280(5):509-517. doi: 10.1111/joim.12519. Epub 2016 May 30.

45.

Reducing exposure to cardiovascular risk factors: the legacy of prevention.

Arsenault BJ, Puri R.

J Thorac Dis. 2016 Sep;8(9):2340-2343. No abstract available.

46.

Rooted in risk: genetic predisposition for low-density lipoprotein cholesterol level associates with diminished low-density lipoprotein cholesterol response to statin treatment.

Smit RA, Postmus I, Trompet S, Barnes MR, Warren H, Arsenault BJ, Chasman DI, Cupples LA, Hitman GA, Krauss RM, Li X, Psaty BM, Stein CM, Rotter JI, Jukema JW.

Pharmacogenomics. 2016 Oct;17(15):1621-1628. Epub 2016 Sep 20.

47.

Meta-analysis of genome-wide association studies of HDL cholesterol response to statins.

Postmus I, Warren HR, Trompet S, Arsenault BJ, Avery CL, Bis JC, Chasman DI, de Keyser CE, Deshmukh HA, Evans DS, Feng Q, Li X, Smit RA, Smith AV, Sun F, Taylor KD, Arnold AM, Barnes MR, Barratt BJ, Betteridge J, Boekholdt SM, Boerwinkle E, Buckley BM, Chen YI, de Craen AJ, Cummings SR, Denny JC, Dubé MP, Durrington PN, Eiriksdottir G, Ford I, Guo X, Harris TB, Heckbert SR, Hofman A, Hovingh GK, Kastelein JJ, Launer LJ, Liu CT, Liu Y, Lumley T, McKeigue PM, Munroe PB, Neil A, Nickerson DA, Nyberg F, O'Brien E, O'Donnell CJ, Post W, Poulter N, Vasan RS, Rice K, Rich SS, Rivadeneira F, Sattar N, Sever P, Shaw-Hawkins S, Shields DC, Slagboom PE, Smith NL, Smith JD, Sotoodehnia N, Stanton A, Stott DJ, Stricker BH, Stürmer T, Uitterlinden AG, Wei WQ, Westendorp RG, Whitsel EA, Wiggins KL, Wilke RA, Ballantyne CM, Colhoun HM, Cupples LA, Franco OH, Gudnason V, Hitman G, Palmer CN, Psaty BM, Ridker PM, Stafford JM, Stein CM, Tardif JC, Caulfield MJ, Jukema JW, Rotter JI, Krauss RM.

J Med Genet. 2016 Dec;53(12):835-845. doi: 10.1136/jmedgenet-2016-103966. Epub 2016 Sep 1.

48.

Association between plasma lipoprotein levels and bioprosthetic valve structural degeneration.

Nsaibia MJ, Mahmut A, Mahjoub H, Dahou A, Bouchareb R, Boulanger MC, Després JP, Bossé Y, Arsenault BJ, Larose E, Pibarot P, Mathieu P.

Heart. 2016 Dec 1;102(23):1915-1921. doi: 10.1136/heartjnl-2016-309541. Epub 2016 Jul 4.

PMID:
27378363
49.

Emerging Cardiovascular Disease Biomarkers and Incident Diabetes Mellitus Risk in Statin-Treated Patients With Coronary Artery Disease (from the Treating to New Targets [TNT] Study).

Arsenault BJ, Kohli P, Lambert G, DeMicco DA, Laskey R, Messig MM, Kastelein JJ, Waters DD.

Am J Cardiol. 2016 Aug 15;118(4):494-8. doi: 10.1016/j.amjcard.2016.05.044. Epub 2016 May 29.

50.

C-Reactive Protein Identifies Low-Risk Metabolically Healthy Obese Persons: The European Prospective Investigation of Cancer-Norfolk Prospective Population Study.

van Wijk DF, Boekholdt SM, Arsenault BJ, Ahmadi-Abhari S, Wareham NJ, Stroes ES, Khaw KT.

J Am Heart Assoc. 2016 Jun 3;5(6). pii: e002823. doi: 10.1161/JAHA.115.002823.

Supplemental Content

Loading ...
Support Center